DRUG FOR TREATING TUMOR

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230310596A1
SERIAL NO

18003718

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention belongs to the field of biomedicines, relates to a drug for treating tumors, and provides use of an anti-PD-L1 antibody or a pharmaceutical composition thereof in preparation of a drug for treating endometrial cancer. Also provided is use of the anti-PD-L1 antibody or the pharmaceutical composition thereof in preparation of a drug for treating a MSI-H and/or dMMR tumor. In addition, also provided is use of a pharmaceutical combination of the anti-PD-L1 antibody and Anlotinib or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition thereof in preparation of a drug for treating endometrial cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTDNO 369 YUZHOU SOUTH RD LIANYUNGANG JIANGSU 222062 222062

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CHEN, Jie Nanjing City, Jiangsu Province, CN 1059 5911
LI, Kun Nanjing City, Jiangsu Province, CN 342 1288
SU, Nan Nanjing City, Jiangsu Province, CN 18 245
WANG, Rongliang Nanjing City, Jiangsu, CN 2 0
WANG, Xunqiang Nanjing City, Jiangsu Province, CN 24 50
YU, Ding Nanjing City, Jiangsu Province, CN 32 31
ZHANG, Xiquan Nanjing City, Jiangsu Province, CN 77 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation